{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T20:19:53Z","timestamp":1783023593513,"version":"3.54.6"},"reference-count":162,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T00:00:00Z","timestamp":1769385600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008871","name":"Yunnan Provincial Science and Technology Department","doi-asserted-by":"publisher","award":["202101AZ070001\\u2013010"],"award-info":[{"award-number":["202101AZ070001\\u2013010"]}],"id":[{"id":"10.13039\/501100008871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007846","name":"Yunnan Provincial Department of Education","doi-asserted-by":"publisher","award":["2024Y384"],"award-info":[{"award-number":["2024Y384"]}],"id":[{"id":"10.13039\/501100007846","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82260886"],"award-info":[{"award-number":["82260886"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental and Molecular Pathology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.yexmp.2026.105030","type":"journal-article","created":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T22:40:23Z","timestamp":1770158423000},"page":"105030","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Hyperuricemia-induced renal fibrosis: Mechanisms and advances in pharmacological studies using uricase-deficient animal models"],"prefix":"10.1016","volume":"145","author":[{"given":"Jiaxiang","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Yun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weigang","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yexmp.2026.105030_bb0005","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1716153","article-title":"Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis","volume":"379","author":"Adams","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.yexmp.2026.105030_bb0010","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1248\/bpb.b20-00597","article-title":"Renal Reabsorptive transport of uric acid precursor xanthine by URAT1 and GLUT9","volume":"43","author":"Arakawa","year":"2020","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.yexmp.2026.105030_bb0015","doi-asserted-by":"crossref","first-page":"109","DOI":"10.5414\/CN108663","article-title":"Revisiting medullary tophi: a link between uric acid and progressive chronic kidney disease?","volume":"85","author":"Ayoub","year":"2016","journal-title":"Clin. Nephrol."},{"key":"10.1016\/j.yexmp.2026.105030_bb0020","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1056\/NEJMoa1915833","article-title":"Effects of allopurinol on the progression of chronic kidney disease","volume":"382","author":"Badve","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.yexmp.2026.105030_bb0025","doi-asserted-by":"crossref","first-page":"F422","DOI":"10.1152\/ajprenal.00261.2019","article-title":"Medullary and cortical thick ascending limb: similarities and differences","volume":"318","author":"Bankir","year":"2020","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.yexmp.2026.105030_bb0030","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1126\/science.179.4078.1123","article-title":"Purine overproduction in man associated with increased phosphoribosylpyrophosphate synthetase activity","volume":"179","author":"Becker","year":"1973","journal-title":"Science"},{"key":"10.1016\/j.yexmp.2026.105030_bb0035","doi-asserted-by":"crossref","first-page":"5603","DOI":"10.1038\/sj.emboj.7601421","article-title":"Snail activation disrupts tissue homeostasis and induces fibrosis in the adult kidney","volume":"25","author":"Boutet","year":"2006","journal-title":"EMBO J."},{"key":"10.1016\/j.yexmp.2026.105030_bb0040","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/4391920","article-title":"Uric acid induces endothelial dysfunction by activating the HMGB1\/RAGE signaling pathway","volume":"2017","author":"Cai","year":"2017","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.yexmp.2026.105030_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.176640","article-title":"Fasudil attenuates oxidative stress-induced partial epithelial-mesenchymal transition of tubular epithelial cells in hyperuricemic nephropathy via activating Nrf2","volume":"975","author":"Cao","year":"2024","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.yexmp.2026.105030_bb0050","doi-asserted-by":"crossref","first-page":"73","DOI":"10.59556\/japi.72.0724","article-title":"Topiroxostat-a safer Uricostatic drug with enhanced renal protection: a narrative review","volume":"72","author":"Chandrashekara","year":"2024","journal-title":"J. Assoc. Physicians India"},{"key":"10.1016\/j.yexmp.2026.105030_bb0055","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41586-018-0761-3","article-title":"PtdIns4P on dispersed trans-Golgi network mediates NLRP3 inflammasome activation","volume":"564","author":"Chen","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.yexmp.2026.105030_bb0060","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1039\/C6FO01561A","article-title":"Polydatin attenuates potassium oxonate-induced hyperuricemia and kidney inflammation by inhibiting NF-\u03baB\/NLRP3 inflammasome activation via the AMPK\/SIRT1 pathway","volume":"8","author":"Chen","year":"2017","journal-title":"Food Funct."},{"key":"10.1016\/j.yexmp.2026.105030_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.envpol.2025.126749","article-title":"Inulin alleviates intestinal changes caused by gestational PFOA and GenX exposure in the offspring of mice through reshaping maternal gut microbiota and vertically inhibiting the TLR4\/NF-\u03baB\/NLRP3 inflammatory pathway in the pups","volume":"382","author":"Chen","year":"2025","journal-title":"Environ. Pollut."},{"key":"10.1016\/j.yexmp.2026.105030_bb0070","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ijcard.2008.09.004","article-title":"Uric acid activates extracellular signal-regulated kinases and thereafter endothelin-1 expression in rat cardiac fibroblasts","volume":"139","author":"Cheng","year":"2010","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.yexmp.2026.105030_bb0075","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1186\/s12891-015-0762-4","article-title":"Factors influencing the crystallization of monosodium urate: a systematic literature review","volume":"16","author":"Chhana","year":"2015","journal-title":"BMC Musculoskelet. Disord."},{"key":"10.1016\/j.yexmp.2026.105030_bb0080","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1053\/j.ajkd.2007.05.013","article-title":"Relationship of uric acid with progression of kidney disease","volume":"50","author":"Chonchol","year":"2007","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.yexmp.2026.105030_bb0085","author":"Clinical trials.gov"},{"key":"10.1016\/j.yexmp.2026.105030_bb0090","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00240-010-0282-5","article-title":"Pro-inflammatory and oxidative effects of noncrystalline uric acid in human mesangial cells: contribution to hyperuricemic glomerular damage","volume":"39","author":"Convento","year":"2011","journal-title":"Urol. Res."},{"key":"10.1016\/j.yexmp.2026.105030_bb0095","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ejim.2022.04.022","article-title":"Uric acid in metabolic syndrome: does uric acid have a definitive role?","volume":"103","author":"Copur","year":"2022","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.yexmp.2026.105030_bb0100","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/535686","article-title":"Renal oxidative stress induced by long-term hyperuricemia alters mitochondrial function and maintains systemic hypertension","volume":"2015","author":"Crist\u00f3bal-Garc\u00eda","year":"2015","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.yexmp.2026.105030_bb0105","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.867260","article-title":"The role of M1\/M2 macrophage polarization in rheumatoid arthritis synovitis","volume":"13","author":"Cutolo","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.yexmp.2026.105030_bb0110","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1002\/art.40159","article-title":"Lesinurad, a selective uric acid reabsorption inhibitor, in combination with Febuxostat in patients with Tophaceous gout: findings of a phase III clinical trial","volume":"69","author":"Dalbeth","year":"2017","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.yexmp.2026.105030_bb0115","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.molmed.2017.06.005","article-title":"Molecular pathophysiology of gout","volume":"23","author":"Desai","year":"2017","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.yexmp.2026.105030_bb0120","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.vascn.2013.05.006","article-title":"Adenine-induced chronic kidney and cardiovascular damage in rats","volume":"68","author":"Diwan","year":"2013","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.yexmp.2026.105030_bb0125","series-title":"Uox\u2212\/\u2212 da shu zu zhi qi guan niao suan fen bu ji sheng wu xue ping jia [uric acid distribution in Uox\u2212\/\u2212 rat\u2019s tissues and their biological evaluation]","author":"Dong","year":"2021"},{"key":"10.1016\/j.yexmp.2026.105030_bb0130","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1056\/NEJMoa1916624","article-title":"Serum urate lowering with allopurinol and kidney function in type 1 diabetes","volume":"382","author":"Doria","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.yexmp.2026.105030_bb0135","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.3109\/0886022X.2014.947516","article-title":"Hyperuricemia and chronic kidney disease: an enigma yet to be solved","volume":"36","author":"Dousdampanis","year":"2014","journal-title":"Ren. Fail."},{"key":"10.1016\/j.yexmp.2026.105030_bb0140","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1159\/000518254","article-title":"Direct blood pressure-independent anti-fibrotic effects by the selective nonsteroidal mineralocorticoid receptor antagonist Finerenone in progressive models of kidney fibrosis","volume":"52","author":"Droebner","year":"2021","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.yexmp.2026.105030_bb0145","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s12882-019-1275-4","article-title":"Hyperuricemia and its related histopathological features on renal biopsy","volume":"20","author":"Fan","year":"2019","journal-title":"BMC Nephrol."},{"key":"10.1016\/j.yexmp.2026.105030_bb0150","doi-asserted-by":"crossref","first-page":"5587642","DOI":"10.1155\/2021\/5587642","article-title":"Aboriginal bacterial Flora in the uricase-deficient rat gut is not the main factor affecting serum uric acid","volume":"2021","author":"Fan","year":"2021","journal-title":"Evid. Based Complement. Alternat. Med."},{"key":"10.1016\/j.yexmp.2026.105030_bb0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0256594","article-title":"Uricase deficiency causes mild and multiple organ injuries in rats","volume":"16","author":"Fan","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.yexmp.2026.105030_bb0160","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1007\/s00467-013-2549-x","article-title":"Uric acid and the kidney","volume":"29","author":"Fathallah-Shaykh","year":"2014","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.yexmp.2026.105030_bb0165","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1159\/000492853","article-title":"Short-chain fatty acids manifest Stimulative and protective effects on intestinal barrier function through the inhibition of NLRP3 Inflammasome and autophagy","volume":"49","author":"Feng","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.yexmp.2026.105030_bb0170","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1001\/jama.1966.03110150075021","article-title":"Long-term effect of probenecid on diuretic-induced hyperuricemia","volume":"198","author":"Freis","year":"1966","journal-title":"Jama"},{"key":"10.1016\/j.yexmp.2026.105030_bb0175","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1080\/14728222.2018.1420167","article-title":"ABCG2 as a therapeutic target candidate for gout","volume":"22","author":"Fujita","year":"2018","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.yexmp.2026.105030_bb0180","article-title":"Uricase-deficient rats with similarly stable serum uric acid to human's are sensitive model animals for studying hyperuricemia","volume":"17","author":"Gao","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.yexmp.2026.105030_bb0185","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.hlc.2016.02.022","article-title":"Role of renal oxidative stress in the pathogenesis of the Cardiorenal syndrome","volume":"25","author":"Giam","year":"2016","journal-title":"Heart Lung Circ."},{"key":"10.1016\/j.yexmp.2026.105030_bb0190","doi-asserted-by":"crossref","DOI":"10.3390\/cells11040626","article-title":"Asymptomatic hyperuricemia promotes recovery from ischemic organ injury by modulating the phenotype of macrophages","volume":"11","author":"Gnemmi","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.yexmp.2026.105030_bb0195","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/j.humpath.2009.02.020","article-title":"Direct contribution of epithelium to organ fibrosis: epithelial-mesenchymal transition","volume":"40","author":"Guarino","year":"2009","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.yexmp.2026.105030_bb0200","article-title":"Intestinal microbiota distinguish gout patients from healthy humans","volume":"6","author":"Guo","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.yexmp.2026.105030_bb0205","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1007\/s00394-020-02414-x","article-title":"Inulin supplementation ameliorates hyperuricemia and modulates gut microbiota in Uox-knockout mice","volume":"60","author":"Guo","year":"2021","journal-title":"Eur. J. Nutr."},{"key":"10.1016\/j.yexmp.2026.105030_bb0210","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1161\/01.CIR.0000066420.36123.35","article-title":"Uric acid predicts clinical outcomes in heart failure: insights regarding the role of xanthine oxidase and uric acid in disease pathophysiology","volume":"107","author":"Hare","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.yexmp.2026.105030_bb0215","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.15878","article-title":"Association of uric acid-lowering therapy with incident chronic kidney disease","volume":"5","author":"Hassan","year":"2022","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.yexmp.2026.105030_bb0220","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1021\/acsptsci.5c00197","article-title":"Limosilactobacillus fermentum M5e attenuates hyperuricemia and renal injury via dual modulation of gut microbiota and purine metabolic pathways","volume":"8","author":"He","year":"2025","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.yexmp.2026.105030_bb0225","article-title":"Transcutaneous assessment of renal function in conscious rodents","volume":"e53767","author":"Herrera P\u00e9rez","year":"2016","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.yexmp.2026.105030_bb0230","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.ceca.2012.01.003","article-title":"Hyperuricemia induces endothelial dysfunction via mitochondrial Na+\/Ca2+ exchanger-mediated mitochondrial calcium overload","volume":"51","author":"Hong","year":"2012","journal-title":"Cell Calcium"},{"key":"10.1016\/j.yexmp.2026.105030_bb0235","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/8387654","article-title":"High concentrations of uric acid and angiotensin II act additively to produce endothelial injury","volume":"2020","author":"Hong","year":"2020","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.yexmp.2026.105030_bb0240","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1111\/bph.14978","article-title":"Perfecting a high hypoxanthine phosphoribosyltransferase activity-uricase KO mice to test the effects of purine- and non-purine-type xanthine dehydrogenase (XDH) inhibitors","volume":"177","author":"Hosoya","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.yexmp.2026.105030_bb0245","author":"Hou","year":"2021"},{"key":"10.1016\/j.yexmp.2026.105030_bb0250","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1007\/s40265-018-0983-6","article-title":"Patisiran: first global approval","volume":"78","author":"Hoy","year":"2018","journal-title":"Drugs"},{"key":"10.1016\/j.yexmp.2026.105030_bb0255","article-title":"The SGLT2 inhibitor dapagliflozin ameliorates renal fibrosis in hyperuricemic nephropathy","volume":"5","author":"Hu","year":"2024","journal-title":"Cell. Rep. Med."},{"key":"10.1016\/j.yexmp.2026.105030_bb0260","first-page":"957","article-title":"Research progress in the influence of urate-lowering agents on hyperuricemia associated multiple systematic complications","volume":"42","author":"Huang","year":"2022","journal-title":"Chin. J. Hosp. Pharm."},{"key":"10.1016\/j.yexmp.2026.105030_bb0265","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s40261-020-00941-3","article-title":"Long-term safety and effectiveness of the xanthine oxidoreductase inhibitor, Topiroxostat in Japanese Hyperuricemic patients with or without gout: a 54-week open-label, multicenter, post-marketing observational study","volume":"40","author":"Ishikawa","year":"2020","journal-title":"Clin. Drug Investig."},{"key":"10.1016\/j.yexmp.2026.105030_bb0270","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1159\/000362456","article-title":"Relationship between serum uric acid and serum oxidative stress markers in the Japanese general population","volume":"128","author":"Ishizaka","year":"2014","journal-title":"Nephron Clin. Pract."},{"key":"10.1016\/j.yexmp.2026.105030_bb0275","doi-asserted-by":"crossref","DOI":"10.3346\/jkms.2019.34.e307","article-title":"Association between serum uric acid and metabolic syndrome in Koreans","volume":"34","author":"Jeong","year":"2019","journal-title":"J. Korean Med. Sci."},{"key":"10.1016\/j.yexmp.2026.105030_bb0280","first-page":"1452","article-title":"Osteoarthritis and mitochondrial abnormalities","volume":"26","author":"Jin","year":"2022","journal-title":"Chin. J. Tissue Eng. Res."},{"key":"10.1016\/j.yexmp.2026.105030_bb0285","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1159\/000484278","article-title":"Hyperuricemia and progression of chronic kidney disease: role of phenotype transition of renal tubular and endothelial cells","volume":"192","author":"Kang","year":"2018","journal-title":"Contrib. Nephrol."},{"key":"10.1016\/j.yexmp.2026.105030_bb0290","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.2174\/1381612827666210104124320","article-title":"Serum uric acid and diabetes: from pathophysiology to cardiovascular disease","volume":"27","author":"Katsiki","year":"2021","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.yexmp.2026.105030_bb0295","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/apha.12026","article-title":"Renal pericytes: regulators of medullary blood flow","volume":"207","author":"Kennedy-Lydon","year":"2013","journal-title":"Acta Physiol (Oxford)"},{"key":"10.1016\/j.yexmp.2026.105030_bb0300","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3389\/fphar.2017.00010","article-title":"C5a regulates IL-1\u03b2 production and leukocyte recruitment in a murine model of monosodium urate crystal-induced peritonitis","volume":"8","author":"Khameneh","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.yexmp.2026.105030_bb0305","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s10157-004-0292-0","article-title":"Crystal-induced inflammation of the kidneys: results from human studies, animal models, and tissue-culture studies","volume":"8","author":"Khan","year":"2004","journal-title":"Clin. Exp. Nephrol."},{"key":"10.1016\/j.yexmp.2026.105030_bb0310","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9103204","article-title":"Systemic urate deposition: an unrecognized complication of gout?","volume":"9","author":"Khanna","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.yexmp.2026.105030_bb0315","doi-asserted-by":"crossref","first-page":"F993","DOI":"10.1152\/ajprenal.00637.2014","article-title":"Hyperuricemia-induced NLRP3 activation of macrophages contributes to the progression of diabetic nephropathy","volume":"308","author":"Kim","year":"2015","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.yexmp.2026.105030_bb0320","article-title":"Association between serum uric acid level and ESRD or death in a Korean population","volume":"35","author":"Kim","year":"2020","journal-title":"J. Korean Med. Sci."},{"key":"10.1016\/j.yexmp.2026.105030_bb0325","doi-asserted-by":"crossref","first-page":"7444","DOI":"10.3390\/ijms21207444","article-title":"The crucial role of xanthine oxidase in CKD progression associated with hypercholesterolemia","volume":"21","author":"Kim","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.yexmp.2026.105030_bb0330","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1053\/j.ajkd.2018.06.028","article-title":"Febuxostat therapy for patients with stage 3 CKD and asymptomatic hyperuricemia: a randomized trial","volume":"72","author":"Kimura","year":"2018","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.yexmp.2026.105030_bb0335","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1093\/eurheartj\/ehz119","article-title":"Febuxostat for cerebral and cardiorenovascular events prevention study","volume":"40","author":"Kojima","year":"2019","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.yexmp.2026.105030_bb0340","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1093\/rheumatology\/keab739","article-title":"Optimal uric acid levels by febuxostat treatment and cerebral, cardiorenovascular risks: post hoc analysis of a randomized controlled trial","volume":"61","author":"Kojima","year":"2022","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.yexmp.2026.105030_bb0345","doi-asserted-by":"crossref","first-page":"3763","DOI":"10.1073\/pnas.1320393111","article-title":"Evolutionary history and metabolic insights of ancient mammalian uricases","volume":"111","author":"Kratzer","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.yexmp.2026.105030_bb0350","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/s10157-016-1288-2","article-title":"Time to target uric acid to retard CKD progression","volume":"21","author":"Kumagai","year":"2017","journal-title":"Clin. Exp. Nephrol."},{"key":"10.1016\/j.yexmp.2026.105030_bb0355","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/nrm3758","article-title":"Molecular mechanisms of epithelial-mesenchymal transition","volume":"15","author":"Lamouille","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.yexmp.2026.105030_bb0360","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.7150\/ijbs.7.1056","article-title":"Diverse roles of TGF-\u03b2\/Smads in renal fibrosis and inflammation","volume":"7","author":"Lan","year":"2011","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.yexmp.2026.105030_bb0365","doi-asserted-by":"crossref","first-page":"527","DOI":"10.3899\/jrheum.180761","article-title":"Hepatic safety of Febuxostat compared with allopurinol in gout patients with fatty liver disease","volume":"46","author":"Lee","year":"2019","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.yexmp.2026.105030_bb0370","first-page":"853","article-title":"Advances in the regulatory effects of exosomes on NLRP3 inflammasome","volume":"60","author":"Li","year":"2025","journal-title":"Acta Pharm. Sin."},{"key":"10.1016\/j.yexmp.2026.105030_bb0375","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/1471-2369-15-122","article-title":"Is hyperuricemia an independent risk factor for new-onset chronic kidney disease?: a systematic review and meta-analysis based on observational cohort studies","volume":"15","author":"Li","year":"2014","journal-title":"BMC Nephrol."},{"key":"10.1016\/j.yexmp.2026.105030_bb0380","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.108605","article-title":"IL-25 improves diabetic wound healing through stimulating M2 macrophage polarization and fibroblast activation","volume":"106","author":"Li","year":"2022","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.yexmp.2026.105030_bb0385","article-title":"Differences of uric acid transporters carrying extracellular vesicles in the urine from uric acid and calcium stone formers and non-stone formers","volume":"23","author":"Lin","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.yexmp.2026.105030_bb0390","doi-asserted-by":"crossref","first-page":"R60","DOI":"10.1186\/ar4497","article-title":"Pegloticase immunogenicity: the relationship between efficacy and antibody development in patients treated for refractory chronic gout","volume":"16","author":"Lipsky","year":"2014","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.yexmp.2026.105030_bb0395","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2023.117262","article-title":"Fuling-Zexie formula attenuates hyperuricemia-induced nephropathy and inhibits JAK2\/STAT3 signaling and NLRP3 inflammasome activation in mice","volume":"319","author":"Lu","year":"2024","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.yexmp.2026.105030_bb0400","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jmii.2017.12.004","article-title":"Monosodium urate crystals induced ICAM-1 expression and cell-cell adhesion in renal mesangial cells: implications for the pathogenesis of gouty nephropathy","volume":"53","author":"Luo","year":"2020","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"10.1016\/j.yexmp.2026.105030_bb0405","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/ki.2014.287","article-title":"Origin of myofibroblasts and cellular events triggering fibrosis","volume":"87","author":"Mack","year":"2015","journal-title":"Kidney Int."},{"key":"10.1016\/j.yexmp.2026.105030_bb0410","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1053\/j.ajkd.2008.12.021","article-title":"Uric acid and long-term outcomes in CKD","volume":"53","author":"Madero","year":"2009","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.yexmp.2026.105030_bb0415","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ijcard.2015.08.109","article-title":"Regulation of uric acid metabolism and excretion","volume":"213","author":"Maiuolo","year":"2016","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.yexmp.2026.105030_bb0420","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1093\/intimm\/dxu090","article-title":"IL-10 enhances the phenotype of M2 macrophages induced by IL-4 and confers the ability to increase eosinophil migration","volume":"27","author":"Makita","year":"2015","journal-title":"Int. Immunol."},{"key":"10.1016\/j.yexmp.2026.105030_bb0425","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1007\/s11926-013-0400-9","article-title":"The crystallization of monosodium urate","volume":"16","author":"Martillo","year":"2014","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.yexmp.2026.105030_bb0430","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1161\/HYPERTENSIONAHA.111.171488","article-title":"Effect of a reduction in uric acid on renal outcomes during losartan treatment: a post hoc analysis of the reduction of endpoints in non-insulin-dependent diabetes mellitus with the angiotensin II antagonist losartan trial","volume":"58","author":"Miao","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.yexmp.2026.105030_bb0435","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1681\/ASN.2019111160","article-title":"Multifunctional natural polymer nanoparticles as Antifibrotic gene carriers for CKD therapy","volume":"31","author":"Midgley","year":"2020","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.yexmp.2026.105030_bb0440","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/127013","article-title":"Association of PRPS1 mutations with disease phenotypes","volume":"2015","author":"Mittal","year":"2015","journal-title":"Dis. Markers"},{"key":"10.1016\/j.yexmp.2026.105030_bb0445","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1016\/j.ymthe.2021.02.016","article-title":"Imbalance of TGF-\u03b21\/BMP-7 pathways induced by M2-polarized macrophages promotes hepatocellular carcinoma aggressiveness","volume":"29","author":"Ning","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.yexmp.2026.105030_bb0450","doi-asserted-by":"crossref","first-page":"5056","DOI":"10.2174\/0929867326666181211094421","article-title":"Mechanistic insights of soluble uric acid-related kidney disease","volume":"27","author":"Pan","year":"2020","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.yexmp.2026.105030_bb0455","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adj0133","article-title":"Inhibition of MERTK reduces organ fibrosis in mouse models of fibrotic disease","volume":"16","author":"Pan","year":"2024","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.yexmp.2026.105030_bb0460","first-page":"110","article-title":"Advantages of therapy with sodium glucose cotransporter type 2 inhibitors in patients with type 2 diabetes mellitus in combination with hyperuricemia and gout","volume":"92","author":"Panevin","year":"2020","journal-title":"Ter. Arkh."},{"key":"10.1016\/j.yexmp.2026.105030_bb0465","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2023.167009","article-title":"A stable liver-specific urate oxidase gene knockout hyperuricemia mouse model finds activated hepatic de novo purine biosynthesis and urate nephropathy","volume":"1870","author":"Pang","year":"2024","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"key":"10.1016\/j.yexmp.2026.105030_bb0470","doi-asserted-by":"crossref","DOI":"10.7573\/dic.212581","article-title":"Efficacy and safety of lesinurad for the treatment of hyperuricemia in gout","volume":"8","author":"P\u00e9rez-Ruiz","year":"2019","journal-title":"Drugs Context"},{"key":"10.1016\/j.yexmp.2026.105030_bb0475","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.redox.2015.09.017","article-title":"Role of S-Nitrosylation in the extrinsic apoptotic signalling pathway in cancer","volume":"5","author":"Plenchette","year":"2015","journal-title":"Redox Biol."},{"key":"10.1016\/j.yexmp.2026.105030_bb0480","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1152\/physrev.00009.2021","article-title":"Regulation of solute carriers oct2 and OAT1\/3 in the kidney: a phylogenetic, ontogenetic, and cell dynamic perspective","volume":"102","author":"Pou Casellas","year":"2022","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.yexmp.2026.105030_bb0485","doi-asserted-by":"crossref","DOI":"10.5812\/numonthly.7(3)2015.27233","article-title":"Associations between hyperuricemia and chronic kidney disease: a review","volume":"7","author":"Prasad Sah","year":"2015","journal-title":"Nephrourol. Mon."},{"key":"10.1016\/j.yexmp.2026.105030_bb0490","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.156440","article-title":"Linarin attenuates hyperuricemic nephropathy by modulating Nrf2\/Keap1 and TLR4\/NF-\u03baB signaling pathways: linarin attenuates hyperuricemic nephropathy","volume":"139","author":"Qian","year":"2025","journal-title":"Phytomedicine"},{"key":"10.1016\/j.yexmp.2026.105030_bb0495","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.amjhyper.2005.08.005","article-title":"Effect of losartan versus candesartan on uric acid, renal function, and fibrinogen in patients with hypertension and hyperuricemia associated with diuretics","volume":"19","author":"Rayner","year":"2006","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.yexmp.2026.105030_bb0500","first-page":"2093","article-title":"Rasburicase for tophaceous gout not treatable with allopurinol: an exploratory study","volume":"34","author":"Richette","year":"2007","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.yexmp.2026.105030_bb0505","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/s42003-024-06534-6","article-title":"Unraveling the pathological biomineralization of monosodium urate crystals in gout patients","volume":"7","author":"Rodriguez-Navarro","year":"2024","journal-title":"Commun. Biol."},{"key":"10.1016\/j.yexmp.2026.105030_bb0510","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/rheumatology\/kez384","article-title":"Monosodium urate crystal interleukin-1\u03b2 release is dependent on toll-like receptor 4 and transient receptor potential V1 activation","volume":"59","author":"Rossato","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.yexmp.2026.105030_bb0515","doi-asserted-by":"crossref","first-page":"476","DOI":"10.3389\/fphys.2018.00476","article-title":"Human mutations in SLC2A9 (Glut9) affect transport capacity for urate","volume":"9","author":"Ruiz","year":"2018","journal-title":"Front. Physiol."},{"key":"10.1016\/j.yexmp.2026.105030_bb0520","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/ki.1990.261","article-title":"Countercurrent system","volume":"38","author":"Sands","year":"1990","journal-title":"Kidney Int."},{"key":"10.1016\/j.yexmp.2026.105030_bb0525","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s00467-022-05620-3","article-title":"Longitudinal changes in uric acid concentration and their relationship with chronic kidney disease progression in children and adolescents","volume":"38","author":"Schwartz","year":"2023","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.yexmp.2026.105030_bb0530","doi-asserted-by":"crossref","first-page":"6370","DOI":"10.4049\/jimmunol.177.9.6370","article-title":"Engagement of CD14 mediates the inflammatory potential of monosodium urate crystals","volume":"177","author":"Scott","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.yexmp.2026.105030_bb0535","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1517\/13543784.2015.1051617","article-title":"Investigational drugs for hyperuricemia","volume":"24","author":"Shahid","year":"2015","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.yexmp.2026.105030_bb0540","doi-asserted-by":"crossref","first-page":"6425","DOI":"10.1002\/jcp.26429","article-title":"Macrophage plasticity, polarization, and function in health and disease","volume":"233","author":"Shapouri-Moghaddam","year":"2018","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.yexmp.2026.105030_bb0545","article-title":"Losses of human disease-associated genes in placental mammals","volume":"2","author":"Sharma","year":"2020","journal-title":"NAR Genom. Bioinform."},{"key":"10.1016\/j.yexmp.2026.105030_bb0550","first-page":"1374","article-title":"TLR4\/NF-\u03baB axis signaling pathway-dependent up-regulation of miR-625-5p contributes to human intervertebral disc degeneration by targeting COL1A1","volume":"11","author":"Shen","year":"2019","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.yexmp.2026.105030_bb0555","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1172\/JCI42344","article-title":"Uric acid transport and disease","volume":"120","author":"So","year":"2010","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.yexmp.2026.105030_bb0560","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2023.116736","article-title":"Integrated network pharmacology and gut microbiome analysis to reveal the mechanism of Qu-Zhuo-Tong-bi decoction against hyperuricemia and gout","volume":"316","author":"Song","year":"2023","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.yexmp.2026.105030_bb0565","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1053\/j.ajkd.2017.08.017","article-title":"Uric acid and the risks of kidney failure and death in individuals with CKD","volume":"71","author":"Srivastava","year":"2018","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.yexmp.2026.105030_bb0570","doi-asserted-by":"crossref","first-page":"e2347","DOI":"10.1210\/clinem\/dgaa748","article-title":"Dapagliflozin added to Verinurad plus Febuxostat further reduces serum uric acid in hyperuricemia: the QUARTZ study","volume":"106","author":"Stack","year":"2021","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.yexmp.2026.105030_bb0575","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/5817348","article-title":"Research advances in the mechanisms of hyperuricemia-induced renal injury","volume":"2020","author":"Su","year":"2020","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.yexmp.2026.105030_bb0580","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1016\/j.bbadis.2018.03.009","article-title":"Benzbromarone aggravates hepatic steatosis in obese individuals","volume":"1864","author":"Sun","year":"2018","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"key":"10.1016\/j.yexmp.2026.105030_bb0585","doi-asserted-by":"crossref","first-page":"938","DOI":"10.3390\/pharmaceutics16070938","article-title":"Targeting liver Xor by GalNAc-siRNA is an effective strategy for hyperuricemia therapy","volume":"16","author":"Sun","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.yexmp.2026.105030_bb0590","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1002\/acr.25547","article-title":"Risk of hepatotoxicity in patients with gout treated with Febuxostat or Benzbromarone: a propensity score-matched cohort study","volume":"77","author":"Sun","year":"2025","journal-title":"Arthritis Care Res."},{"key":"10.1016\/j.yexmp.2026.105030_bb0595","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1136\/ard.62.6.572","article-title":"Effects of combination treatment using anti-hyperuricaemic agents with fenofibrate and\/or losartan on uric acid metabolism","volume":"62","author":"Takahashi","year":"2003","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.yexmp.2026.105030_bb0600","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/s41598-017-00706-7","article-title":"Discovery and characterization of verinurad, a potent and specific inhibitor of URAT1 for the treatment of hyperuricemia and gout","volume":"7","author":"Tan","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.yexmp.2026.105030_bb0605","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1080\/13880209.2020.1871373","article-title":"Inosine induces acute hyperuricaemia in rhesus monkey (Macaca mulatta) as a potential disease animal model","volume":"59","author":"Tang","year":"2021","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.yexmp.2026.105030_bb0610","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.5551\/jat.63199","article-title":"Association between serum uric acid and impaired endothelial function: the circulatory risk in communities study","volume":"29","author":"Tang","year":"2022","journal-title":"J. Atheroscler. Thromb."},{"key":"10.1016\/j.yexmp.2026.105030_bb0615","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1152\/ajprenal.00480.2018","article-title":"Blockade of ERK1\/2 by U0126 alleviates uric acid-induced EMT and tubular cell injury in rats with hyperuricemic nephropathy","volume":"316","author":"Tao","year":"2019","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.yexmp.2026.105030_bb0620","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1002\/art.42447","article-title":"Serum urate-lowering efficacy and safety of Tigulixostat in gout patients with hyperuricemia: a randomized, double-blind, placebo-controlled, dose-finding trial","volume":"75","author":"Terkeltaub","year":"2023","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.yexmp.2026.105030_bb0625","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s41232-018-0070-0","article-title":"CTGF in kidney fibrosis and glomerulonephritis","volume":"38","author":"Toda","year":"2018","journal-title":"Inflamm. Regen."},{"key":"10.1016\/j.yexmp.2026.105030_bb0630","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1161\/CIRCRESAHA.115.306565","article-title":"Cardiac fibrosis: the fibroblast awakens","volume":"118","author":"Travers","year":"2016","journal-title":"Circ. Res."},{"key":"10.1016\/j.yexmp.2026.105030_bb0635","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0330344","article-title":"Uricase deficiency in rats results in a variety of metabolic disorders, addition to gouty nephropathy","volume":"20","author":"Wan","year":"2025","journal-title":"PLoS One"},{"key":"10.1016\/j.yexmp.2026.105030_bb0640","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/JLB.3RU1018-378RR","article-title":"M2b macrophage polarization and its roles in diseases","volume":"106","author":"Wang","year":"2019","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.yexmp.2026.105030_bb0645","doi-asserted-by":"crossref","first-page":"3697","DOI":"10.2147\/DDDT.S321879","article-title":"Puerarin alleviates UUO-induced inflammation and fibrosis by regulating the NF-\u03baB P65\/STAT3 and TGF\u03b21\/Smads signaling pathways","volume":"15","author":"Wang","year":"2021","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.yexmp.2026.105030_bb0650","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.946832","article-title":"Macrophage autophagy in macrophage polarization, chronic inflammation and organ fibrosis","volume":"13","author":"Wen","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.yexmp.2026.105030_bb0655","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1016\/j.cellsig.2013.04.005","article-title":"TNFR1 signaling kinetics: spatiotemporal control of three phases of IKK activation by posttranslational modification","volume":"25","author":"Workman","year":"2013","journal-title":"Cell. Signal."},{"key":"10.1016\/j.yexmp.2026.105030_bb0660","doi-asserted-by":"crossref","DOI":"10.1038\/emm.2017.287","article-title":"Impaired Na+-K+-ATPase signaling in renal proximal tubule contributes to hyperuricemia-induced renal tubular injury","volume":"50","author":"Xiao","year":"2018","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.yexmp.2026.105030_bb0665","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/1756-185X.12648","article-title":"A phase 3, multicenter, randomized, allopurinol-controlled study assessing the safety and efficacy of oral febuxostat in Chinese gout patients with hyperuricemia","volume":"18","author":"Xu","year":"2015","journal-title":"Int. J. Rheum. Dis."},{"key":"10.1016\/j.yexmp.2026.105030_bb0670","doi-asserted-by":"crossref","first-page":"100852","DOI":"10.18632\/oncotarget.20135","article-title":"Recent advances on uric acid transporters","volume":"8","author":"Xu","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.yexmp.2026.105030_bb0675","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41419-020-02824-z","article-title":"TLR4 promotes microglial pyroptosis via lncRNA-F630028O10Rik by activating PI3K\/AKT pathway after spinal cord injury","volume":"11","author":"Xu","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.yexmp.2026.105030_bb0680","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2147\/JIR.S500101","article-title":"Tigulixostat alleviates Hyperuricemic nephropathy by promoting M2 macrophage polarization","volume":"18","author":"Xue","year":"2025","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.yexmp.2026.105030_bb0685","doi-asserted-by":"crossref","first-page":"450","DOI":"10.3390\/cells13050450","article-title":"A possible therapeutic application of the selective inhibitor of urate transporter 1, Dotinurad, for metabolic syndrome, chronic kidney disease, and cardiovascular disease","volume":"13","author":"Yanai","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.yexmp.2026.105030_bb0690","doi-asserted-by":"crossref","first-page":"F336","DOI":"10.1152\/ajprenal.00053.2010","article-title":"Uric acid increases fibronectin synthesis through upregulation of lysyl oxidase expression in rat renal tubular epithelial cells","volume":"299","author":"Yang","year":"2010","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.yexmp.2026.105030_bb0695","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1186\/s12882-019-1506-8","article-title":"Uric acid regulates NLRP3\/IL-1\u03b2 signaling pathway and further induces vascular endothelial cells injury in early CKD through ROS activation and K+ efflux","volume":"20","author":"Yin","year":"2019","journal-title":"BMC Nephrol."},{"key":"10.1016\/j.yexmp.2026.105030_bb0700","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1111\/1756-185X.14434","article-title":"Jian pi Shen Shi formula alleviates hyperuricemia and related renal fibrosis in uricase-deficient rats via suppression of the collagen-binding pathway","volume":"25","author":"Yin","year":"2022","journal-title":"Int. J. Rheum. Dis."},{"key":"10.1016\/j.yexmp.2026.105030_bb0705","doi-asserted-by":"crossref","first-page":"5033","DOI":"10.2147\/DDDT.S86884","article-title":"Pharmacokinetics, pharmacodynamics, and tolerability of LC350189, a novel xanthine oxidase inhibitor, in healthy subjects","volume":"9","author":"Yoon","year":"2015","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.yexmp.2026.105030_bb0710","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.15999","article-title":"Dieting alleviates hyperuricemia and organ injuries in uricase-deficient rats via down-regulating cell cycle pathway","volume":"11","author":"Yu","year":"2023","journal-title":"PeerJ"},{"key":"10.1016\/j.yexmp.2026.105030_bb0715","doi-asserted-by":"crossref","first-page":"6551","DOI":"10.1038\/s41467-025-61226-x","article-title":"Molecular mechanism of drug inhibition of URAT1","volume":"16","author":"Yu","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.yexmp.2026.105030_bb0720","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s40620-015-0216-y","article-title":"Sulodexide alone or in combination with low doses of everolimus inhibits the hypoxia-mediated epithelial to mesenchymal transition in human renal proximal tubular cells","volume":"28","author":"Zaza","year":"2015","journal-title":"J. Nephrol."},{"key":"10.1016\/j.yexmp.2026.105030_bb0725","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s00109-003-0517-9","article-title":"The role of epithelial-to-mesenchymal transition in renal fibrosis","volume":"82","author":"Zeisberg","year":"2004","journal-title":"J. Mol. Med. (Berl)"},{"key":"10.1016\/j.yexmp.2026.105030_bb0730","doi-asserted-by":"crossref","first-page":"1095487","DOI":"10.3389\/fphar.2023.1095487","article-title":"Dapagliflozin alleviates renal fibrosis in a mouse model of adenine-induced renal injury by inhibiting TGF-\u03b21\/MAPK mediated mitochondrial damage","volume":"14","author":"Zeng","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.yexmp.2026.105030_bb0735","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1080\/10408398.2018.1517725","article-title":"A next generation probiotic, Akkermansia muciniphila","volume":"59","author":"Zhai","year":"2019","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"10.1016\/j.yexmp.2026.105030_bb0740","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1080\/13543776.2023.2277249","article-title":"N-acetylgalactosamine delivery systems for RNA therapeutics: a patent perspective","volume":"33","author":"Zhang","year":"2023","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.yexmp.2026.105030_bb0745","article-title":"Prevalence of hyperuricemia among Chinese adults: findings from two nationally representative cross-sectional surveys in 2015-16 and 2018-19","volume":"12","author":"Zhang","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.yexmp.2026.105030_bb0750","doi-asserted-by":"crossref","DOI":"10.3390\/md19050238","article-title":"Fucoidan from Laminaria japonica inhibits expression of GLUT9 and URAT1 via PI3K\/Akt, JNK and NF-\u03baB pathways in uric acid-exposed HK-2 cells","volume":"19","author":"Zhang","year":"2021","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.yexmp.2026.105030_bb0755","article-title":"Role of the CCL2-CCR2 axis in cardiovascular disease: pathogenesis and clinical implications","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.yexmp.2026.105030_bb0760","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2022.153387","article-title":"Uric acid accumulation in the kidney triggers mast cell degranulation and aggravates renal oxidative stress","volume":"483","author":"Zhang","year":"2023","journal-title":"Toxicology"},{"key":"10.1016\/j.yexmp.2026.105030_bb0765","first-page":"3051","article-title":"The gut microbiota characteristics of athletes","volume":"29","author":"Zhang","year":"2025","journal-title":"Chin. J. Tissue Eng. Res."},{"key":"10.1016\/j.yexmp.2026.105030_bb0770","first-page":"300","article-title":"Research progress in the genetics of hyperuricaemia and gout","volume":"38","author":"Zheng","year":"2016","journal-title":"Yi Chuan"},{"key":"10.1016\/j.yexmp.2026.105030_bb0775","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nature09663","article-title":"A role for mitochondria in NLRP3 inflammasome activation","volume":"469","author":"Zhou","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.yexmp.2026.105030_bb0780","article-title":"Uric acid induces renal inflammation via activating tubular NF-\u03baB signaling pathway","volume":"7","author":"Zhou","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.yexmp.2026.105030_bb0785","doi-asserted-by":"crossref","first-page":"7664","DOI":"10.1039\/D1FO00911G","article-title":"Glycopeptides from Paecilomyces sinensis ameliorate ethanol-induced gastric ulcers via anti-inflammation and the miR-9-5p-MEK\/ERK signaling pathway","volume":"12","author":"Zhou","year":"2021","journal-title":"Food Funct."},{"key":"10.1016\/j.yexmp.2026.105030_bb0790","doi-asserted-by":"crossref","DOI":"10.1080\/0886022X.2023.2238825","article-title":"Serum uric acid is associated with chronic kidney disease in elderly Chinese patients with diabetes","volume":"45","author":"Zhou","year":"2023","journal-title":"Ren. Fail."},{"key":"10.1016\/j.yexmp.2026.105030_bb0795","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.175616","article-title":"Puerarin protects against sepsis-associated encephalopathy by inhibiting NLRP3\/Caspase-1\/GSDMD pyroptosis pathway and reducing blood-brain barrier damage","volume":"945","author":"Zhou","year":"2023","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.yexmp.2026.105030_bb0800","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s40168-024-01826-9","article-title":"Gut microbiota dysbiosis in hyperuricaemia promotes renal injury through the activation of NLRP3 inflammasome","volume":"12","author":"Zhou","year":"2024","journal-title":"Microbiome"},{"key":"10.1016\/j.yexmp.2026.105030_bb0805","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1002\/art.30520","article-title":"Prevalence of gout and hyperuricemia in the US general population: the National Health and nutrition examination survey 2007-2008","volume":"63","author":"Zhu","year":"2011","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.yexmp.2026.105030_bb0810","first-page":"1","article-title":"Analysis of the efficacy and safety of Benzbromarone combined with sodium bicarbonate tablets in the treatment of hyperuricemia","volume":"85","author":"Zhu","year":"2024","journal-title":"Br. J. Hosp. Med. (Lond.)"}],"container-title":["Experimental and Molecular Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014480026000092?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014480026000092?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T19:37:37Z","timestamp":1783021057000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014480026000092"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":162,"alternative-id":["S0014480026000092"],"URL":"https:\/\/doi.org\/10.1016\/j.yexmp.2026.105030","relation":{},"ISSN":["0014-4800"],"issn-type":[{"value":"0014-4800","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hyperuricemia-induced renal fibrosis: Mechanisms and advances in pharmacological studies using uricase-deficient animal models","name":"articletitle","label":"Article Title"},{"value":"Experimental and Molecular Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexmp.2026.105030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"105030"}}